Quantum BioPharma Ltd. (QNTM) — Cash Flow-to-Debt Ratio
Quantum BioPharma Ltd. (QNTM) has a Cash Flow-to-Debt Ratio of -0.26x as of September 2025, meaning its operating cash flow of $-1.72 Million could theoretically repay 0% of its total liabilities ($6.65 Million) in one year. Explore QNTM long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Quantum BioPharma Ltd. Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Quantum BioPharma Ltd. across 10 annual periods. Also explore Quantum BioPharma Ltd. assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Quantum BioPharma Ltd. (2015–2024)
Year-by-year debt coverage analysis for Quantum BioPharma Ltd.. For market capitalisation and broader financial context, see Quantum BioPharma Ltd. (QNTM) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.03x | $-6.88 Million | $6.68 Million | ▲ +56.6% |
| 2023 | -2.37x | $-10.83 Million | $4.57 Million | ▲ +34.1% |
| 2022 | -3.60x | $-28.33 Million | $7.87 Million | ▼ -53.3% |
| 2021 | -2.35x | $-20.75 Million | $8.83 Million | ▲ +30.5% |
| 2020 | -3.38x | $-19.13 Million | $5.66 Million | ▼ -71.1% |
| 2019 | -1.98x | $-13.71 Million | $6.94 Million | ▲ +81.4% |
| 2018 | -10.60x | $-13.58 Million | $1.28 Million | ▼ -8857.1% |
| 2017 | -0.12x | $-119.18K | $1.01 Million | ▲ +73.3% |
| 2016 | -0.44x | $-27.24K | $61.43K | ▼ -42203.9% |
| 2015 | 0.00x | $-63.44 | $60.53K | — |